Menotropins (Humegon)

Subscribe to Selected New Research on Menotropins

113 relevant articles (2 outcomes, 8 trials/studies) found for this Drug

Description: Extracts of urine from menopausal women that contain high concentrations of pituitary gonadotropins, FOLLICLE STIMULATING HORMONE and LUTEINIZING HORMONE. Menotropins are used to treat infertility. The FSH:LH ratio and degree of purity vary in different preparations.

Also Known As:

Humegon; Pergonal; CP-89044; CP-90033; Ferring Brand of Menotropins; Fustery Brand of Menotropins; HMG Ferring; HMG Lepori; HMG Massone; Lepori Brand of Menotropins; Menogon; Menopur; Menotrophin; Normegon; ORG-31338; Organon Brand of Menotropins; Organon Teknika Brand of Menotropins; Pergonal-500; Serono Brand of Menotropins; CP 89044; CP 90033; CP89044; CP90033; Human Menopausal Gonadotropins; Lepori, HMG; Menotropins Ferring Brand; Menotropins Fustery Brand; Menotropins Lepori Brand; Menotropins Organon Brand; Menotropins Serono Brand; ORG 31338; ORG31338; Pergonal 500; Pergonal500; Gonadotropins, Human Menopausal; Gonadotropin, menopausal

Relationship Network

Drug Context: Research Results

Experts

1.	Menopur Ovulation Induction (MOI) Study Group: 1 article (07/2006)
2.	Balen, Adam: 1 article (07/2006)
3.	Andersen, Anders Nyboe: 1 article (07/2006)
4.	Sørensen, Per: 1 article (07/2006)
5.	Helmgaard, Lisbeth: 1 article (07/2006)
6.	Arce, Joan-Carles: 1 article (07/2006)
7.	Platteau, Peter: 1 article (07/2006)
8.	Devroey, Paul: 1 article (07/2006)
9.	Laird, S: 1 article (02/2001)
10.	Anstie, B: 1 article (02/2001)

Related Diseases

1.	Infertility (Sterility) 07/01/2006 - "Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study." 09/01/1996 - "As conclusion, it therefore appears appropriate, to offer a treatment with menotropins to that specific group of couples with unexplained infertility with good prognostic factor as age < 30 years and infertility duration < 5 years. " 09/01/1996 - "The objective was to evaluate the utility of the ovarian hyperstimulation with menotropins as treatment of unexplained infertility. " 09/01/1996 - "[Ovarian hyperstimulation with menotropins as treatment for unexplained sterility; effect of reproductive characteristics on the results]" 03/01/1996 - "Minimal stimulation achieves pregnancy rates comparable to human menopausal gonadotropins in the treatment of infertility." Order ALL the reference details at left...
2.	Amenorrhea 01/01/1994 - "Clinico-hormonal parameters of cycles stimulated with human menopausal gonadotropins in patients with hypogonadotropic amenorrhea and of spontaneous cycles in healthy women of reproductive age are compared. " 01/01/1994 - "[Functional state of the reproductive system in patients with the hypogonadotropic form of amenorrhea during use of various protocols of ovulation induction with human menopausal gonadotropins]" 01/01/1993 - "[The characteristics of hypophyseal gonadotropic function in patients with hypogonadotropic amenorrhea against a background of pergonal ovulation stimulation]" 10/01/1989 - "[Comparative analysis of fertile and infertile cycles during stimulation of ovulation with pergonal in patients with hypo- gonadotropic amenorrhea]" 07/01/1985 - "Induction of ovulation with subcutaneous pulsatile (every 90 min.) administration of HMG (Pergonal) 75 or 150 IU/day using a portable pump (Nipro SP-3I) was performed in 3 PCO patients (6 cycles), 4 first grade amenorrhea (Am-I) patients (7 cycles) and 4 Am-II patients (4 cycles). " Order ALL the reference details at left...
3.	Endometriosis (Adenomyosis) 07/01/1992 - "Superovulation with human menopausal gonadotropins in the treatment of infertility associated with minimal or mild endometriosis: a controlled randomized study." 03/01/1992 - "DESIGN AND PATIENTS: Of 67 women with severe endometriosis referred to us for in vitro fertilization-embryo transfer (IVF-ET), 32 underwent ovarian stimulation for oocyte retrieval with menotropins (protocol A), whereas the other 35 were admitted for the procedure after a 6-month period of hormonal suppression with a GnRH agonist (protocol B). " 07/01/1992 - "OBJECTIVE: To determine the efficacy of superovulation with buserelin acetate, human menopausal gonadotropins (hMG), and human chorionic gonadotropin (hCG) in the treatment of infertility associated with minimal or mild endometriosis. " 10/01/1983 - "The initial experience with the use of a portable infusion pump for the delivery of human menopausal gonadotropins (hMG) in the therapy of ovulation dysfunction of women who failed to conceive following (1) either clomiphene citrate (five patients with polycystic ovary syndrome) or danazol (three patients with mild endometriosis) and (2) standard intramuscular hMG-human chorionic gonadotropin therapy is reported. " 11/01/1986 - "The effectiveness of ovulation induction with clomiphene citrate or human menopausal gonadotropins was evaluated in 52 infertile women with stage I or stage II endometriosis and ovulatory dysfunction: anovulation or luteinized unruptured follicle (LUF) syndrome before (group I) and after (group II) danazol treatment. " Order ALL the reference details at left...
4.	Oligospermia (Oligozoospermia) 09/01/1974 - "Human menopausal gonadotropins in the treatment of patients with oligospermia." 07/01/1971 - "[Treatment results in oligospermia with HMG (Pergonal 500). " 03/01/1980 - "Here are reported results of a study based on the administration during 13 weeks of Pergonal-Profasi, in cases of oligozoospermia. " 01/01/1967 - "Effects of human chorionic gonadotropin and human menopausal gonadotropin (pergonal) in males with oligospermia." Order ALL the reference details at left...
5.	Ovarian Neoplasms (Ovarian Cancer) 08/01/2001 - "The SKOV-3 human ovarian cancer cell line was tested for uPA secretory responses (enzyme immunoassay of conditioned media) after treatments with sex steroids, human menopausal gonadotropins (hMG), or gonadotropin-releasing hormone (GnRH). " 05/01/1991 - "The present in vitro study investigated effects of human gonadotropin (Pergonal LH/FSH, 1:1) and Lupron, a GnRH agonist, on proliferation of an ovarian cancer cell line, 2774, which is estrogen receptor negative and grows well in serum-free, defined medium. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Gonadotropins
2.	Chorionic Gonadotropin (Human Chorionic Gonadotropin)
3.	Buserelin (Suprefact)
4.	Menotropins (Humegon)
5.	Gonadotropin-Releasing Hormone (GnRH)
6.	Estrogens (Estrogen)
7.	Leuprolide (Lupron)
8.	Growth Hormone (Somatotropin)
9.	Profasi
10.	Clomiphene (Clomifene)

Related Therapies and Procedures

1.	Intramuscular Injections
2.	Injections
3.	Infusion Pumps (Infusion Pump)
4.	Curettage
5.	Aftercare (After-Treatment)

Best Treatments:
Research Summary Report
on Infertility

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 241 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>